SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artículo

AVEZUM, Álvaro et al. ¿Cómo reducir los accidentes cerebrovasculares en Latinoamérica? Parte 1. Insuf. card. [online]. 2012, vol.7, n.2, pp. 71-88. ISSN 1852-3862.

    1. World Health Organization. Deaths from stroke. In: The Atlas of Heart Disease and Stroke. Mackay J, Menash G (editors) Geneva, Switzerland: World Health Organization; 2004. http://www.who. int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf. Acceso en febrero de 2011. [ Links ]

    2. World Health Organization. The global burden of disease: 2004 update. 2008. http://www.who.int/healthinfo/global_burden_disease/ GBD_report_2004update_full.pdf. Acceso en marzo de 2011. [ Links ]

    3. World Health Organization. The global burden of disease: 2004 update. Disease and injury country estimates. Death and DALY estimates for 2004 by cause for WHO Member States. 2009. http://www.who.int/entity/healthinfo/global_burden_disease/ gbddeathdalycountryestimates2004.xls. Acceso en febrero de 2011. [ Links ]

    4. Yach D, Hawkes C, Gould CL et al. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004;291:2616-22. [ Links ]

    5. Wolfe C, Rudd A. The Burden of Stroke White Paper: Raising awareness of the global toll of stroke-related disability and death. 2007. http://www.safestroke.org/Portals/10/FINAL Burden of Stroke.pdf. Acceso en marzo de 2011. [ Links ]

    6. Wolfe CD. The impact of stroke. Br Med Bull 2000;56:275-86. [ Links ]

    7. Carod-Artal FJ, Ferreira CL, Trizotto DS et al. Burden and perceived health status among caregivers of stroke patients. Cerebrovasc Dis 2009;28:472-80. [ Links ]

    8. World Health Organization. The global burden of disease: 2004 update. Regional burden of disease estimates for 2004. Incidence and prevalence for MDG regions. 2008. http://www.who.int/ healthinfo/global_burden_disease/estimates_regional/en/index. html. Acceso en marzo de 2011. [ Links ]

    9. Christensen MC, Previgliano I, Capparelli FJ et al. Acute treatment costs of intracerebral hemorrhage and ischemic stroke in Argentina. Acta Neurol Scand 2009;119:246-53. [ Links ]

    10. Christensen MC, Valiente R, Sampaio SG et al. Acute treatment costs of stroke in Brazil. Neuroepidemiology 2009;32:142-9. [ Links ]

    11. Du X, McNamee R, Cruickshank K. Stroke risk from multiple risk factors combined with hypertension: a primary care based case-control study in a defined population of northwest England. Ann Epidemiol 2000;10:380-8. [ Links ]

    12. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8. [ Links ]

    13. Marini C, De Santis F, Sacco S et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005;36:1115-9. [ Links ]

    14. Gage BF, Waterman AD, Shannon W et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70. [ Links ]

    15. Lip GY, Nieuwlaat R, Pisters R et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: The Euro Heart Survey on Atrial Fibrillation. Chest 2010;137:263-72. [ Links ]

    16. Lamassa M, Di Carlo A, Pracucci G et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke 2001;32:392-8. [ Links ]

    17. Iqbal MB, Taneja AK, Lip GY et al. Recent developments in atrial fibrillation. BMJ 2005;330:238-43. [ Links ]

    18. Jørgensen HS, Nakayama H, Reith J et al. Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke 1996;27:1765-9. [ Links ]

    19. Cantú-Brito C, Ruiz-Sandoval JL, Murillo- Bonilla LM et al. The first Mexican multicenter register on ischaemic stroke (the PREMIER study): demographics, risk factors and outcome. Int J Stroke 2011;6:93-4. [ Links ]

    20. Zimerman LI, Fenelon G, Martinelli Filho M et al. Sociedade Brasileira de Cardiologia. Diretrizes Brasileiras de Fibrilação Atrial. Arq Bras Cardiol 2009;92:1-39. [ Links ]

    21. Fuenmayor AJ, Fuenmayor AM. Non pharmacological treatment of atrial fibrillation. Avances Cardiol 2009;29: 286-95. [ Links ]

    22. Lip GY, Lim HS. Atrial fibrillation and stroke prevention.
    Lancet Neurol 2007;6:981-93. [ Links ]

    23. Bungard TJ, Ghali WA, Teo KK et al. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000;160:41-6. [ Links ]

    24. Gladstone DJ, Bui E, Fang J et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 2009;40:235-40. [ Links ]

    25. Hirsh J, Dalen J, Anderson DR et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119:8S-21S. [ Links ]

    26. Turpie AG. Warfarin replacements: mechanisms underlying emerging agents. Can J Cardiol 2008;24 Supl C:56C-60C. [ Links ]

    27. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;150:396-404. [ Links ]

    28. Dorsch MP, Lee JS, Lynch DR et al. Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction. Ann Pharmacother 2007;41:737-41. [ Links ]

    29. Palikhe NS, Kim SH, Park HS. What do we know about the genetics of aspirin intolerance? J Clin Pharm Ther 2008;33:465-72. [ Links ]

    30. Patel D, Moonis M. Clinical implications of aspirin resistance. Expert Rev Cardiovasc Ther 2007;5:969-75. [ Links ]

    31. Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-e354. [ Links ]

    32. Kirchhof P, Auricchio A, Bax J et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007;9:1006-23. [ Links ]

    33. Pan American Health Organization. Health in the Americas 2007 Volume 4 - Regional. Chapter 4 - Public policies and health systems and services. Scientific and technical publication No. 622. 2007. http://www.paho.org/hia/vol1regionalingcap4.html. Acceso en marzo de 2011. [ Links ]

    34. Pan American Health Organization. Health in the Americas 2007 Volume 1 - Regional. Chapter 1 - Health in the context of development. Scientific and technical publication No. 622. 2007. http://www.paho.org/hia/archivosvol1/volregionaling/HIA07 Regional Volume ENG Ch 1.pdf. Acceso en marzo de 2011. [ Links ]

    35. Morris K. UN raises priority of noncommunicable diseases. Lancet 2010;375:1859. [ Links ]

    36. Pan American Health Organization. Regional strategy and plan of action on an integrated approach to the prevention and control of chronic diseases. 2007. http://www.paho.org/english/ad/dpc/nc/reg-strat-cncds.pdf. Acceso en marzo de 2011. [ Links ]

    37. Ministers of Health of the Americas. Health agenda for the Americas 2008-2017. 2007. http://new.paho.org/hq/dmdocuments/2009/Health_Agenda_for_the_Americas_2008-2017.pdf. Acceso en marzo de 2011. [ Links ]

    38. Pan American Health Organization. PanAmerican STEPS, the PAHO/WHO stepwise approach to chronic noncommunicable disease risk-factor surveillance. 2010. http://www.paho.org/ English/AD/DPC/NC/panam-steps.htm. Acceso en marzo de 2011. [ Links ]

    39. World Health Organization. The global burden of disease: 2004 update. Disease and injury regional estimates for 2004. Deaths for MDG regions. 2008. http://www.who.int/entity/healthinfo/global_burden_disease/DTHMDG 2004.xls. Acceso en marzo de 2011. [ Links ]

    40. World Health Organization. Cardiovascular diseases (CVDs): Fact sheet No. 317. 2011. http://www.who.int/mediacentre/factsheets/fs317/en/index.html. Acceso en marzo de 2011 41. [ Links ]

    World Health Summit 2010- Partner Information. Challenging the worldwide cardiovascular crisis. 2010. http://www.worldhealthsummit.org/index.php?id=384. Acceso en febrero de 2011. [ Links ]

    42. World Health Organization. The global burden of disease: 2004 update. Projections of mortality and burden of disease, 2004-2030. Projected deaths for MDG regions, baseline. 2008. http://www.who.int/entity/healthinfo/global_burden_disease/ DthMDG_2030.xls. Acceso en marzo de 2011. [ Links ]

    43. World Health Organization. Preventing chronic diseases: a vital investment. 2005. http://www.who.int/chp/chronic_disease_report/ full_report.pdf. Acceso en marzo de 2011. [ Links ]

    44. World Health Organization. The World Health Report 2003: shaping the future. 2003. http://www.who.int/whr/2003/en/ whr03_en.pdf. Acceso en marzo de 2011 [ Links ]

    45. Pan American Health Organization. STEPwise approach to stroke surveillance (STEPS Stroke). 2010.http://www.paho.org/English/AD/DPC/NC/steps-stroke.htm. Acceso en marzo de 2011. [ Links ]

    46. Hart RG, Benavente O, McBride R et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a metaanalysis. Ann Intern Med 1999;131:492-501. [ Links ]

    47. Hart RG, Pearce LA, Aguilar MI. Metaanalysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-67. [ Links ]

    48. Singer DE, Albers GW, Dalen JE et al. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:429S-56S. [ Links ]

    49. Murphy NF, Simpson CR, Jhund PS et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 2007;93:606-12. [ Links ]

    50. de Miranda AP, Ciabotti GP, Zabukas DV et al. The art state of atrial fibrillation. Rev Bras Clin Med 2009;7:261-6. [ Links ]

    51. Kawabata-Yoshihara LA, Bensenor IM, Kawabata VS et al. Prevalence of electrocardiographic findings in elderly individuals: the Sao Paulo aging & health study. Arq Bras Cardiol 2009;93:602-6. [ Links ]

    52. Kirchhof P, Bax J, Blomstrom-Lundquist C et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J 2009;30:2969-77c. [ Links ]

    53. Bungard TJ, Ghali WA, McAlister FA et al. Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation. Can Med Assoc J 2001;165:301-2. [ Links ]

    54. Man-Son-Hing M, Laupacis A. Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded. Arch Intern Med 2003;163:1580-6. [ Links ]

    55. Friberg L, Hammar N, Ringh M et al. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J 2006;27:1954-64. [ Links ]

    56. Macedo PG, Ferreira NE, Silva BT et al. Anticoagulação oral em pacientes com fibrilação atrial: das diretrizes prática clínica. Rev Assoc Med Bras 2010;56: 56-61. [ Links ]

    57. Sobral Filho DC, da Costa IF, de Melo ME et al. Principais causas da sub-utilização de anticoagulantes orais em pacientes com fibrilação atrial associada a fatores de risco para tromboembolismo. Relampa 2005;18:222. Resumen 76. [ Links ]

    58. Cantu C, Arauz A, Ruiz-Sandoval JL et al. Underuse of antithrombotic therapy and clinical outcome in patients with acute ischemic stroke and atrial fibrillation in a Hispanic population. Stroke 2011;42:e346-e347. Resumen P323. [ Links ]

    59. Fornari LS, Calderaro D, Nassar IB et al. Misuse of antithrombotic therapy in atrial fibrillation patients: frequent, pervasive and persistent. J Thromb Thrombolysis 2007;23:65-71. [ Links ]

    60. Nieuwlaat R, Olsson SB, Lip GY et al. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Am Heart J 2007;153:1006-12. [ Links ]

    61. American Heart Association. Get with guidelines - Stroke overview. 2011. http://www.heart.org/HEARTORG/HealthcareResearch/ GetWithTheGuidelinesHFStroke/GetWith-TheGuidelinesStrokeHomePage/Get-With-The-Guidelines- Stroke-Overview_UCM_308021_Article.jsp. Acceso en marzo de 2011. [ Links ]

    62. Camm AJ, Kirchhof P, Lip GY et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429. [ Links ]

    63. Fuster V, Ryden LE, Cannom DS et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. Circulation 2011;123:e269-e367. [ Links ]

    64. Consejo de Salubridad General. Diagnóstico y tratamiento de la fibrilación auricular. 2009. http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/014_GPC_FibrilacionAuricular/ SS_014_08_GRR.pdf. Acceso en marzo de 2011. [ Links ]

    65. Sociedad Argentina de Cardiología. Consenso de fibrilación auricular. Rev Argent Cardiol 2005;73:469-85. [ Links ]

    66. Easton JD, Saver JL, Albers GW et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009;40:2276-93. [ Links ]

    67. Chandratheva A, Mehta Z, Geraghty OC et al. Population-based study of risk and predictors of stroke in the first few hours after a AIT. Neurology 2009;72:1941-7. [ Links ]

    68. World Health Organization. The atlas of heart disease and stroke. 2004. http://www.who.int/cardiovascular_diseases/resources/atlas/en. Acceso en febrero de 2011. [ Links ]

    69. Cantu-Brito C, Majersik JJ, Sánchez BN et al. Door-to-door capture of incident and prevalent stroke cases in Durango, Mexico: the brain attack surveillance in Durango study. Stroke 2011;42:601-6. [ Links ]

    70. Cantu-Brito C, Majersik JJ, Sánchez BN et al. Hospitalized stroke surveillance in the community of Durango, Mexico: the brain attack surveillance in Durango study. Stroke 2010;41:878-84. [ Links ]

    71. Lavados PM, Sacks C, Prina L et al. Incidence, 30-day casefatality rate, and prognosis of stroke in Iquique, Chile: a 2-year communitybased prospective study (PISCIS project). Lancet 2005;365:2206-15. [ Links ]

    72. Minelli C, Fen LF, Minelli DP. Stroke incidence, prognosis, 30-day, and 1-year case fatality rates in Matao, Brazil: a populationbased prospective study. Stroke 2007;38:2906-11. [ Links ]

    73. United Nations. Population Division Department of Economic and Social Affairs. World population ageing 1950-2050. Annexes. Countries or areas. Brazil. 2002. http://www.un.org/esa/ population/publications/worldageing19502050/pdf/052brazi.pdf. Acceso en marzo de 2011. [ Links ]

    74. United Nations. Population Division Department of Economic and Social Affairs. World population ageing 1950-2050. Executive summary New York. 2002. http://www.un.org/esa/population/publications/worldageing19502050/pdf/62executivesummary_english.pdf. Acceso en marzo de 2011. [ Links ]

    75. Daniel K, Wolfe CD, Busch MA et al. What are the social consequences of stroke for working-aged adults? A systematic review. Stroke 2009;40:e431-40. [ Links ]

    76. Bevan H, Sharma K, Bradley W. Stroke in young adults. Stroke 1990;21:382-6. [ Links ]

    77. Camargo EC, Bacheschi LA, Massaro AR. Stroke in Latin America. Neuroimaging Clin N Am 2005;15:283-96. [ Links ]

    78. Morgenstern LB, Smith MA, Lisabeth LD et al. Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol 2004;160:376-83. [ Links ]

    79. Simpson JR, Zahuranec DB, Lisabeth LD et al. Mexican Americans with atrial fibrillation have more recurrent strokes than do non-Hispanic whites. Stroke 2010;41:2132-6. [ Links ]

    80. Cabral NL, Goncalves AR, Longo AL et al. Incidence of stroke subtypes, prognosis and prevalence of risk factors in Joinville, Brazil: a 2 year community based study. J Neurol Neurosurg Psychiatry 2009;80:755-61. [ Links ]

    81. Kappelle LJ, Adams HP, Jr., Heffner ML et al. Prognosis of young adults with ischemic stroke. A long-term follow-up study assessing recurrent vascular events and functional outcome in the Iowa Registry of Stroke in Young Adults. Stroke 1994;25:1360-5. [ Links ]

    82. Mayo NE, Wood-Dauphinee S, Ahmed S et al. Disablement following stroke. Disabil Rehabil 1999;21:258-68. [ Links ]

    83. Díaz TV, Illanes DS, Reccius MA et al. Evaluación de una unidad de tratamiento del ataque cerebral en un hospital universitario. Rev Med Chil 2006;134:1402-8. [ Links ]

    84. Martínez HR, Rangel-Guerra RA, Marfil-Rivera A et al. Cost of stroke in Mexico. J Stroke Cerebrovasc Dis 1995;5:244-7. [ Links ]

    85. Asplund K, Marké L-Å, Terént A et al. Costs and gains in stroke prevention: European perspective. Cerebrovasc Dis 1993;3 Supl 1:34-42. [ Links ]

    86. Kannel WB, Wolf PA, Benjamin EJ et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9N. [ Links ]

    87. The European Stroke Organization (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457-507. [ Links ]

    88. Kjellström T, Norrving B, Shatchkute A. Helsingborg Declaration 2006 on European stroke strategies. Cerebrovasc Dis 2007;23:231-41. [ Links ]

    89. Marmot MG, Poulter NR. Primary prevention of stroke. Lancet 1992;339:344-7. [ Links ]

    90. American College of Cardiology. CardioSmart. Atrial fibrillation. 2010. http://www.cardiosmart.org/HeartDisease/CTT. aspx?id=222. Acceso en junio de 2011. [ Links ]

    91. Hart RG, Pearce LA. Current status of stroke risk stratification in patients with atrial fibrillation. Stroke 2009;40:2607-10. [ Links ]

    92. Pieri A, Spitz M, Lopes TO et al. Prevalence of cardiovascular risk factors among elderly Brazilians over eighty with ischemic stroke. Arq Neuropsiquiatr 2008;66:454-7. [ Links ]

    93. NHS Choices. Atrial fibrillation. 2009. http://www.nhs.uk/conditions/Atrial-fibrillation. Acceso en febrero de 2011. [ Links ]

    94. Lip GY, Beevers DG, Singh SP et al. ABC of atrial fibrillation. Aetiology, pathophysiology, and clinical features. BMJ 1995;311:1425-8. [ Links ]

    95. Labadet C, Liniadot G, Ferreiros ER et al. Resultados del Primer Estudio Nacional, multicéntrico y prospectivo de fibrilación auricular crónica en la República Argentina. Rev Argent Cardiol 2001;69:49-67. [ Links ]

    96. Gudbjartsson DF, Arnar DO, Helgadottir A et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007;448:353-7. [ Links ]

    97. Aizer A, Gaziano JM, Cook NR et al. Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol 2009;103:1572-7. [ Links ]

    98. Farrar MW, Bogart DB, Chapman SS et al. Atrial fibrillation in athletes. Mo Med 2006;103:297-301. [ Links ]

    99. National Institute for Health and Clinical Excellence. Understanding NICE guidance: atrial fibrillation. 2006.http://www.nice.org.uk/nicemedia/pdf/CG036publicinfo.pdf. Acceso en abril de 2011. [ Links ]

    100. National Collaborating Centre for Chronic Conditions. Atrial fibrillation: national clinical guideline for management in primary and secondary care. 2006. http://www.nice.org.uk/nicemedia/pdf/cg036fullguideline.pdf. Acceso en febrero de 2011. [ Links ]

    101. AF AWARE. FA AWARE cardiology groups call for greater awareness and better education on atrial fibrillation. Press release 2009. http://www.world-heartfederation. org/press/press-releases/detail/article/af-aware-cardiology-groups-call-forgreater-awareness-and-better-educationon-atrial-fibrillation. Acceso en marzo de 2011. [ Links ]

    102. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. [ Links ]

    103. Heeringa J, van der Kuip DAM, Hofman A et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006;27:949-53. [ Links ]

    104. Lloyd-Jones DM, Wang TJ, Leip EP et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-6. [ Links ]

    105. Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol 2007;6:1106-14. [ Links ]

    106. Hobbs FD, Fitzmaurice DA, Mant J et al. A randomized controlled trial and costeffectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 2005;9:1-74. [ Links ]

    107. National Institute for Health and Clinical Excellence. Atrial fibrillation: the management of atrial fibrillation. NICE Clinical Guideline 36. London: NICE; 2006. http://www.nice.org.uk/ nicemedia/pdf/CG036niceguideline.pdf. Acceso en febrero de 2011. [ Links ]

    108. Truelsen T, Piechowski-Jozwiak B, Bonita R et al. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 2006;13:581-98. [ Links ]

    109. Cabin HS, Clubb KS, Hall C et al. Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol 1990;65:1112-6. [ Links ]

    110. Stewart S, Hart CL, Hole DJ et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year followup of the Renfrew/Paisley study. Am J Med 2002;113:359-64. [ Links ]

    111. Hughes M, Lip GY. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk strati fication schema and cost effectiveness data. Thromb Haemost 2008;99:295-304. [ Links ]

    112. Frost L, Vukelic AL, Godtfredsen J et al. Age and risk of stroke in atrial fibrillation: evidence for guidelines? Neuroepidemiology 2007;28:109-15. [ Links ]

    113. Lip GY, Frison L, Halperin JL et al. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke 2010;41:2731-8. [ Links ]

    114. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57. [ Links ]

    115. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991;84:527-39. [ Links ]

    116. Baruch L, Gage BF, Horrow J et al. Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified? Stroke 2007;38:2459-63. [ Links ]

    117. Stroke Risk in Atrial Fibrillation Working Group. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke 2008;39:1901-10. [ Links ]

    118. Goto S, Bhatt DL, Rother J et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J 2008;156:855-63. [ Links ]

    119. Poli D, Lip GY, Antonucci E et al. Stroke risk stratification in a 'real-world' elderly anticoagulated atrial fibrillation population. J Cardiovasc Electrophysiol 2011;22:25-30. [ Links ]

    120. van Staa TP, Setakis E, Di Tanna GL et al. A comparison of risk stratification schema for stroke in 79884 atrial fibrillation patients in general practice. J Thromb Haemost 2010;9:39-48. [ Links ]

    121. Pisters R, Lane DA, Nieuwlaat R et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138:1093-100. [ Links ]